Home » Newsletters » BioWorld Science

BioWorld Science

April 30, 1997

View Archived Issues

NCI identifies compounds effective against aggressive human tumors

Preclinical results of IL-12 for chronic viral disease

Didox/Trimidox demonstrate antiretroviral activity in murine model

BMS-200475: profile of a novel anti-hepatitis B compound

ISIS-5320: preclinical study results

Novel cardiac antiischemic agents disclosed by Kanebo

Endothelin antagonists reported by Kowa

Kissei prepares smooth muscle cell proliferation inhibitors

GABA-B antagonists from Novartis

Roche discloses human renin inhibitors

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

Guidant and Neuroperfusion to further develop device for stroke

Preclinical studies with GPI-2A reported by Genesys Pharma

New treatment for Wilson's disease now available

Abbott discovers potent topical immunosuppressant with minimal systemic effects

Schering-Plough develops potent farnesyltransferase inhibitor

Vertex designs potent, conformationally restricted HIV protease inhibitors

Calcium antagonist shown to cause left ventricular hypertrophy regression

Astra: Q1 1997 highlights

Centocor: Q1 1997 highlights

Genzyme Tissue Repair: Q1 1997 highlights

Penederm: Q1 1997 highlights

Xoma: Q1 1997 highlights

Positive preclinical results for T-330 in animal models of gastric ulcers

Dendrimer polyanions with activity against RSV

Advances in novel drug delivery at Inex

Company Profile: Kimeragen

Company Profile: MethylGene

Cambridge NeuroScience achieves new position of strength

Potent inhibitors of HIV-1 and other enveloped viruses reported

Trimeris prepares potent peptide inhibitors of viral fusion

Fluvastatin safe and effective in hypercholesterolemic patients on probucol

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...